The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced ...
Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...
The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.
Starting in 2026, Medicare will implement a $2,000 annual cap on out-of-pocket drug spending. This change is in the Inflation ...
In mid-June, the Medicare Trustees Report had estimated the Part B premium would rise by a scorching-hot 11.5% to $206.20 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback